These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Bishop JA; Sharma R; Illei PB Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516 [TBL] [Abstract][Full Text] [Related]
4. Thyroid Transcription Factor-1 Expression in Adenocarcinomas of the Bile Duct. Lino-Silva LS; Salcedo-Hernández RA; García-Gómez MA; Ruiz-García EB; Aguilar-Romero JM; Domínguez-Rodríguez JA; Herrera-Gómez Á; Maldonado-Martínez HA Int J Surg Pathol; 2016 Feb; 24(1):24-8. PubMed ID: 26316052 [TBL] [Abstract][Full Text] [Related]
5. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700 [TBL] [Abstract][Full Text] [Related]
6. Napsin A staining in adrenal cortical neoplasms. Ballard M; Sangoi A; McKenney JK; Troxell M Arch Pathol Lab Med; 2013 Jul; 137(7):883. PubMed ID: 23808457 [No Abstract] [Full Text] [Related]
7. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion. Kim JH; Kim YS; Choi YD; Lee JS; Park CS Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739 [TBL] [Abstract][Full Text] [Related]
8. Napsin A is differentially expressed in sclerosing hemangiomas of the lung. Schmidt LA; Myers JL; McHugh JB Arch Pathol Lab Med; 2012 Dec; 136(12):1580-4. PubMed ID: 23194051 [TBL] [Abstract][Full Text] [Related]
9. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas. Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909 [TBL] [Abstract][Full Text] [Related]
11. Unusual expression of thyroid transcription factor 1 and napsin A in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung. An J; Park S; Sung SH; Cho MS; Kim SC Am J Clin Pathol; 2014 May; 141(5):712-7. PubMed ID: 24713744 [TBL] [Abstract][Full Text] [Related]
12. Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update. Ordóñez NG Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):429-44. PubMed ID: 22531688 [TBL] [Abstract][Full Text] [Related]
13. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963 [TBL] [Abstract][Full Text] [Related]
14. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens. Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420 [TBL] [Abstract][Full Text] [Related]
15. Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma. Johnson H; Cohen C; Fatima N; Duncan D; Siddiqui MT Acta Cytol; 2012; 56(6):596-602. PubMed ID: 23207437 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962 [TBL] [Abstract][Full Text] [Related]
17. Regarding "Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients". Yuen HF; Zhang SD; Wong AS; McCrudden CM; Huang YH; Chan KY; El-Tanani M; Khoo US Breast Cancer Res Treat; 2012 Jan; 131(1):351-2. PubMed ID: 22037786 [No Abstract] [Full Text] [Related]
18. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens. Kim MJ; Shin HC; Shin KC; Ro JY Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737 [TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas. Choi YL; Kim MK; Suh JW; Han J; Kim JH; Yang JH; Nam SJ J Korean Med Sci; 2005 Oct; 20(5):853-9. PubMed ID: 16224162 [TBL] [Abstract][Full Text] [Related]
20. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung. Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]